Table 3.
Oral agents | Injectable agents |
---|---|
Biguanides | Short and rapid-acting human and animal insulins |
Thiazolidinediones (‘glitazones’) | Short and rapid-acting insulin analogues |
Dual PPAR agonists | Medium and long-acting human and animal insulins |
Sulfonylureas | Medium and long-acting insulin analogues |
Meglitinides (‘glinides’) | Mixed insulins |
DPP-4 inhibitors (‘gliptins’) | GLP-1 agonists |
Alpha-glucosidase inhibitors | Combined GLP-1 agonists and insulin |
Amylin analogues | Inhaled agents |
SGLT 2 inhibitors (‘gliflozins’) | Inhaled insulins |
Combination oral preparations |
DPP4, dipeptidyl peptidase 4; GLP-1, glucagon-like peptide 1; PPAR, peroxisome proliferator-activated receptor; SGLT-2, sodium-glucose co-transporter 2.